Development of a new antiproliferative arachydonoylcyclopropilamide (ACPA) releasing nanoparticle-based drug for endometrial cancers by targeting cannabinoid 1 receptors

---

BİLGİÇ E., BOYACIOĞLU Ö., VARAN C., BİLENSOY E., NEMUTLU E., KARAOSMANOĞLU B., ...More

EACR Conference Nanotechnology in Cancer: Engineering for Oncology, 12 - 14 September 2019, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Hacettepe University Affiliated: Yes